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578Objective: This prospective, randomized study assessed the prophylactic effects of indomethacin treatment on
pericardial effusion after aortic surgery.
Methods: Eighty-five patients were found eligible to participate in this double-blind study. Patients were as-
signed to a control group receiving oral placebo or to an indomethacin group receiving 25 mg oral indomethacin
3 times daily for 7 days preoperatively. After aortic surgery, patients were followed up clinically and evaluated for
pericardial effusion with transthoracic echocardiography on the first and seventh postoperative days during hos-
pitalization and at the second and sixth weeks after discharge.
Results: The demographic and the operative data were similar between groups. The surgical interventions in-
cluded Bentall procedure in 63 patients, valve-sparing procedures in 7 patients, and supracoronary ascending
aorta replacement in 15 patients. Hemiarch replacement was performed in 16 patients. No patient in either group
had pericardial effusion after the first postoperative day. At the end of the first week, however, 2 patients had peri-
cardial effusion, at the end of the second week after discharge, 3 patients had pericardial effusion, and at the end of
the sixth week after discharge, 4 patients had PEs. One of the patients who had PE at the end of the sixth week
received indomethacin; the others were all in the control group, a significant difference (P ¼ .019). Five patients
underwent transthoracic echocardiographically guided pericardiocentesis; 4 underwent surgical pericardiocentesis.
Conclusions: Indomethacin may have beneficial effects on the outcomes and incidence of postoperative pericar-
dial effusion after aortic surgery. (J Thorac Cardiovasc Surg 2011;141:578-82)Pericardial effusion (PE) is not uncommon after cardiac sur-
gery. Depending on the methodology used for its detection,
PE has been reported in 1% to 6% of patients.1,2 Although it
is generally reversible and not life threatening, it may evolve
toward cardiac tamponade, a potentially lethal complication.3
Surgery involving the ascending aorta may result in higher
incidence of PE and cardiac tamponade relative to other car-
diac surgical procedures (up to 31.6% and 15.7%, respec-
tively). Prolonged cardiopulmonary bypass (CPB) and
extensive dissection of the heart and the aorta are the main
causes of increased incidence in aortic surgery.2,4
PEs after aortic surgery are often loculated, forming along
the posterior left ventricular wall.5,6 They are often small in
amount and benign, but they may be circumferential and
quite large (which may impede cardiac filling, reduce
cardiac output, and lead to tamponade) or regional and
located in a strategic area incriminated in the development
of arrhythmias.7,8e Department of Cardiovascular Surgery, Ankara University School of Med-
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The Journal of Thoracic and Cardiovascular SurgThe best management of the large PE is controversial.
Some authors advise routine pericardial drainage by pericar-
diocentesis or surgical pericardiotomy irrespective of the
presence of tamponade, claiming diagnostic and therapeutic
benefits.9,10 Although these procedures are generally well
tolerated, they are not innocuous, and some fatalities have
been reported. In addition, it is sometimes impossible to
drain the effusion completely because of a loculated pattern.10
As well as surgical treatment, a variety of pharmacologic
agents have been used to treat PE and pericarditis, including
nonsteroidal anti-inflammatory drugs and steroids.11-14
Because of the multifactorial etiology of postoperative
effusion and the well-known inflammatory response to
CPB, indomethacin, with its ability to inhibit inflammatory
mediators, could have a beneficial effect in decreasing PE
after cardiac surgery. Reports have described the effects of
indomethacin in acute or uremic pericarditis12-15 and in
cardiac tamponade.16 In these studies, the indomethacin dos-
age was kept between 75 and 150 mg daily. On the basis of
this hypothesis, this prospective, randomized study was
planned to assess the effects of prophylactic indomethacin
treatment on postoperative PE after aortic surgery.MATERIALS AND METHODS
From February 2005 to May 2009, a total of 87 patients were screened
and randomly allocated for participation in this study. Inclusion criteria con-
sisted of informed consent, first-time repair of the ascending aorta with orery c February 2011
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CPB ¼ cardiopulmonary bypass
INR ¼ international normalized ratio
PE ¼ pericardial effusion
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cending aortic aneurysms. Exclusion criteria included preoperative effu-
sion, previous gastrointestinal bleeding, cardiac failure, kidney failure,
infections, hematologic disorders, receipt of anti-inflammatory drugs before
hospitalization, indomethacin allergy, requirement for additional proce-
dures such as coronary artery bypass grafting, valvular operations involving
the mitral or tricuspid valve or left ventricular aneurysmectomy, urgent op-
erations, emergency operations on patients who had received indomethacin
for less than 7 days, refusal to participate in the study, participation in an-
other investigational protocol, intraoperative or early in-hospital death,
and prolonged postoperative ventilation.
Written, informed consent was obtained from each patient before starting
the study, and the protocol was approved by the local ethics committee. The
study was a double-blind protocol in which the surgical staff, principal
investigators, and patients were blinded to the assigned therapy. Clinical
data were collected and recorded in the database by independent, blinded
investigators.
Patients were randomly assigned in a double-blind fashion either to
a control group receiving oral placebo or to an indomethacin group receiv-
ing 25 mg oral indomethacin 3 times daily for 7 days before the operation.
Daily administration of 75 mg indomethacin is an average dose used in pre-
vious studies and was the dose most used in the treatment of pericarditis12-15
and cardiac tamponade.16 The same medication was continued for 6 weeks
after the operation.
Standardized anesthesia and surgical protocols were applied, and all the
operations were performed with CPB. Additionally, in some cases total cir-
culatory arrest was established. After the main aortic surgical procedure,
a 36F conventional drain was placed retrosternally in the anterior mediasti-
num overlying the heart and a 16F thin, closed-suction drain system was
placed toward the posterior pericardial cavity.
All the patients received heparin to have achieved an activated clothing
time of about 200 seconds in the first 24 hours and were switched to low–
molecular weight heparin for approximately 3 days. Patients who underwent
aortic valve replacement also received warfarin, and the international nor-
malized ratio (INR) was kept between 2 and 2.5.
The larger mediastinal drains were removed on the first postoperative
day. The thinner drains were kept until the daily drainage was less than
50 mL in 24 hours.
Patients were kept in the intensive care unit and moved to the ward if the
follow-up was uneventful. Transthoracic echocardiography (TTE) was per-
formed on the 1st and 7th postoperative days, and patients were evaluated
for PE. PE was classified as anterior, posterior, or circumferential, and
PEs larger than 10 mm were considered as significant. PE diagnosed in
the first postoperative week was defined as early, with any developing after
the first week defined as late.2 In addition to TTE, routine radiographs and
blood tests, including determination of INR, were carried out. Patients were
discharged at the end of an uneventful ward follow-up.
Patients were called at the end of the second and sixth weeks, and tele-
cardiography, blood counts, C-reactive protein, and INR were studied.
Additional TTE was performed at these times.
Statistical Analysis
Categoric variables are described as percentages and frequencies.
Groups were compared with Pearson c2 and Fisher’s Exact tests.The Journal of Thoracic and CaComparisons between groups were done with the Mann–Whitney
U test.RESULTS
Of the 87 patients found eligible to participate in the
study, 2 were excluded because of surgical mortality and
prolonged ventilation, leaving 85 patients (47 male and 38
female) for analysis. The mean ages of the patients were
50.3  8.3 years (35–77 years) in the indomethacin group
and 47.8  9.9 years (29–72 years) in the control group.
Patient characteristics are reported in Table 1.
The spectrum of surgical interventions included Bentall
procedure (aortic root replacement with an aortic valve
replacement with a composite valve–graft conduit) in 63
cases, valve-sparing procedures (aortic valve repair and as-
cending aorta replacement with a tubular Dacron polyester
fabric graft) in 7 cases, and isolated supracoronary ascend-
ing aorta replacement with a tubular Dacron polyester fabric
graft in 15 cases. Sixteen of all patients also underwent hem-
iarch replacement. There were no significant differences be-
tween the groups with regard to types of surgical procedures
(Table 2).
All the operations were performed with CPB, and 24 pa-
tients (10 in the indomethacin group and 14 in the control
group) were operated on with deep hypothermic cardiac ar-
rest. The crossclamp, CPB, and hypothermic arrest durations
were similar between groups. The operative data are summa-
rized in Table 2.
Two patients in the indomethacin group and 3 in the con-
trol group underwent reexploration for bleeding. Amount of
postoperative bleeding and amounts of blood and blood
products used are listed in Table 2.
Durations of thinner drains were 49.1  5.3 hours in the
indomethacin group and 51.3  7.4 hours in the control
group. This difference was insignificant (Table 2). The
mean INR results, which were similar, are given in Table 2.
No patients in either group had PE after the first postop-
erative day. Two patients in the control group, however, had
significant early PE at the end of the first week. Both these
patients underwent TTE-guided pericardiocentesis. At the
end of the second week after discharge, 3 patients, all in
the control group, had significant PE. Two patients under-
went surgical pericardiocentesis; the other patient under-
went TTE-guided pericardiocentesis. At the end of the
sixth week, late PE was present in 1 patient in the indometh-
acin group and 3 patients in the control group. Two under-
went surgical pericardiocentesis through a subxiphoid
approach, and the remaining 2 were treated with TTE-
guided pericardiocentesis. During hospitalization and
follow-up 8 patients in the control group and only 1 patient
in the indomethacin group had significant PE, a significant
difference (P ¼ .019). Five of these 9 patients had posterior
PE, 2 had circumferential PE, and the remaining 2 had an-
terior PE (Table 2).rdiovascular Surgery c Volume 141, Number 2 579
TABLE 1. Preoperative clinical data
Variable Indomethacin Control P value
No. of patients 41 44
Age (y, mean  SD) 50.3  8.3 47.8  9.9 .347
Sex (male/female ratio) 23:18 24:20 .886
Hypertension 23 22 .574
Diabetes mellitus 12 9 .346
Creatinine>1.5 mg/dL 8 7 .663
Aortic disease
Aneurysm of ascending aorta 17 22 .430
Aneurysm of ascending aorta
and arch
5 7 .623
Dissection of ascending aorta 10 9 .663
Dissection of ascending aorta
and arch
2 2 .664
Marfan syndrome 5 6 .843
Aortic insufficiency 30 32 .963
Aortic stenosis 3 5 .397
Data represent numbers of patients except when otherwise indicated.
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dias were present in 3 patients in the indomethacin group and
in 10 patients in the control group. The difference groups was
statistically significant (P ¼ .046). Five patients who had
supraventricular arrhythmias also had PEs diagnosed (1/41
in the indomethacin group and 4/44 in the control group,
P¼ .202). We did not observe any severe adverse effects re-
lated to indomethacin treatment. Adverse effects that might
be related to indomethacin treatment are listed in Table 2.DISCUSSION
Early PE is a common finding after cardiac surgery.3,4 The
incidence of significant PE is between 1% and 6%.2,17-19 It
has been reported that after aortic surgery PEs are often
loculated and that even small amounts of fluid in the
posteromedial wall, in the posterolateral wall, or along the
free walls of the right atrium and ventricle can
considerably disturb the cardiac functions or cause cardiac
arrhythmias.2,4 In one study, loculated effusions (57%)
were more frequent than were diffuse (42%), with
tamponade in 1.5%; aortic root surgery, however, was
associated with a 6-fold increase in effusions to 31.6%.4
Prolonged CPB and operation durations, extensive surgi-
cal dissection, and postoperative bleeding are the main rea-
sons of increased PE incidence after aortic surgery.
Especially prolonged CPB and extensive surgical dissection
have been reported to cause an inflammatory response,
which may result in such findings as postcardiotomy syn-
drome or pleural effusion. Replacement of an aneurysmal
sac with a synthetic graft also may cause a mass loss in
the mediastinal space, resulting in an inflammatory reaction
in that area.4
Because it is mainly caused by an inflammatory reaction,
anti-inflammatory drugs, such as nonsteroidal anti-580 The Journal of Thoracic and Cardiovascular Surginflammatory drugs and steroids, are commonly used in
the treatment of postoperative effusions and postcardiotomy
syndrome. The anti-inflammatory effects of indomethacin
are known to emerge by inhibiting cyclo-oxygenases. Indo-
methacin decreases the formation of the precursors of pros-
taglandins and thromboxanes from arachidonic acid or by
activating some proliferator-activated receptors and inhibits
cyclo-oxygenase activity. It has also been shown, however,
that some actions of indomethacin are independent of cyclo-
oxygenases.20 Di Pasquale and colleagues14 reported the
beneficial effects of indomethacin in combination with
a statin in patients with acute pericarditis, with a significant
reduction in inflammatory markers and a favorable trend in
hospitalization duration. There have been no reports,
however, of the effects of indomethacin treatment on post-
operative PE.
Use of anticoagulants contributes to 86% of early and
65% of late PE.1We closely followed up the INRs of the pa-
tients involved in our study to maintain adequate values. The
INRs were within reference range in all patients who had PE.
In some cases, PE may be regional and located in a strate-
gic area incriminated in the development of arrhythmias.7,8
In our study, 10 of the patients in the control group had
supraventricular arrhythmias, significantly different from
the indomethacin group (3 patients, P ¼ .0046). Five of
these 13 patients who had arrhythmias also had PE
diagnosed.
Although side effects of indomethacin are not common,
they may occur. The most common side effects are head-
ache, dizziness, nervousness, upset stomach, stomach pain
or cramps, vomiting, diarrhea, and constipation.11-14
Patients in our study group did not have any severe side
effects from indomethacin. We saw dizziness, stomach
pain and cramps, vomiting, diarrhea, and constipation,
which may have been due to indomethacin treatment;
however, there were no significant differences between
groups.
TTE is safe and effective for diagnosing PE after aortic
surgery. We performed follow-up with TTE in the postoper-
ative period and after discharge. TTE is also used for treat-
ment after diagnosis; TTE-guided pericardiocentesis can
be performed successfully in 89% to 97% of the cases.
TTE-guided pericardiocentesis is less successful, however,
in loculated effusions or effusions with fibrins.21,22 Five
patients in our study groups who had PE were successfully
treated with TTE-guided pericardiocentesis. No complica-
tions from the procedure were observed.
When TTE-guided pericardiocentesis is not possible, sur-
gical pericardiocentesis can be performed.22 We performed
surgical pericardiocentesis in 4 cases, all through a subxi-
phoid approach. Left-sided pneumothorax occurred during
1 procedure; however, all patients were successfully treated.
Within the limitations of the low number of patients in our
study, the findings suggest that preoperative indomethacinery c February 2011
TABLE 2. Operative and postoperative data
Variable Indomethacin Control P value
No. of patients 41 44
Operative status .521
Elective 31 36
Emergency 10 8
Operations (no.)
Bentall procedure 29 34 .491
Valve-sparing procedure
(aortic valve repair and
ascending aorta
replacement with tubular
Dacron graft)
3 4 .540
Isolated supracoronary
ascending aorta
replacement with tubular
Dacron graft
6 9 .482
Prosthesis type (no.) .736
Bioprosthesis 5 7
Mechanical prosthesis 24 27
Hemiarch replacement (no.) 7 9 .690
Cardiopulmonary bypass time
(min, mean  SD)
144.3  21.5 153.0  19.9 .744
Crossclamp time (min,
mean  SD)
96.3  17.7 101.2  20.2 .523
Deep hypothermic cardiac
arrest (no.)
10 14 .447
Deep hypothermic cardiac
arrest duration (min,
mean  SD)
25.1  14.7 21.9  12.9 .219
Reexploration (no.) 2 3 .533
Postoperative drainage
(mL, mean  SD)
425  179 513  201 .227
Fresh-frozen plasma used
(units, mean  SD)
3.1  1.7 2.9  1.2 .455
Erythrocyte suspensions used
(units, mean  SD)
1.9  1.0 1.7  0.7 .322
Thrombocyte suspensions
used (units, mean  SD)
3.0  1.1 2.9  1.0 .711
Duration of mediastinal drains
(h, mean  SD)
49.1  5.3 51.3  7.4 .577
Pericardial effusion during
study period (no.)
1 8 .019
Anterior — 2 .264
Posterior 1 4 .202
Circumferential — 2 .264
Early — 2 .264
Late 1 6 .066
International normalized ratio
(mean  SD)
2.14  0.19 2.30  0.21 .667
Supraventricular arrhythmia
(no.)
3 10 .046
In patients with pericardial
effusion
1 4 .202
Intensive care unit stay
(h, mean  SD)
34.3  9.3 31.9  1.2 .455
Hospital stay (d, mean  SD) 9.3  4.1 8.8  3.9 .109
(Continued)
TABLE 2. Continued
Variable Indomethacin Control P value
Complications potentially related to indomethacin (no.)
Dizziness 3 5 .397
Stomach pain 9 5 .189
Stomach cramps 6 5 .654
Vomiting 5 6 .843
Diarrhea 3 3 .929
Constipation 4 3 .622
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cidence of postoperative PE after aortic surgery. Prophylac-
tic indomethacin therapy may be established as an
alternative protocol regimen to avoid postoperative PE. Fur-
ther investigations with larger numbers patients, however,
are needed.P
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